NCT02262793View on ClinicalTrials.gov

Relative Bioavailability of Telmisartan and Dipyridamole After Co-administration Compared to the Bioavailability of Telmisartan or Dipyridamole Alone in Healthy Female and Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

July 31, 2004

Conditions
Healthy
Interventions
DRUG

telmisartan

DRUG

ASA/ER-DP

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02262793 - Relative Bioavailability of Telmisartan and Dipyridamole After Co-administration Compared to the Bioavailability of Telmisartan or Dipyridamole Alone in Healthy Female and Male Subjects | Biotech Hunter | Biotech Hunter